| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015648157 |
| P356 | DOI | 10.1186/1423-0127-16-14 |
| P932 | PMC publication ID | 2653525 |
| P698 | PubMed publication ID | 19272186 |
| P5875 | ResearchGate publication ID | 24187523 |
| P2093 | author name string | Bor-Show Tzang | |
| Tsai-Ching Hsu | |||
| Chun-Chou Tsai | |||
| Gwo-Jong Hsu | |||
| Szu-Yi Chiang | |||
| P2860 | cites work | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 |
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Management of antiphospholipid antibody syndrome: a systematic review | Q28195454 | ||
| Matrix metalloproteinase-9 and autoimmune diseases | Q28237731 | ||
| IL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes | Q28574764 | ||
| The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity | Q33228419 | ||
| The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity | Q33340668 | ||
| Parvovirus B19 infection and autoimmune disease | Q33348893 | ||
| Human parvovirus B19 infection and antiphospholipid antibodies | Q33374810 | ||
| Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein | Q33374966 | ||
| Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies | Q33388194 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Parvovirus B19. | Q34294811 | ||
| Gelatinase B: a tuner and amplifier of immune functions. | Q34382936 | ||
| VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones | Q34813312 | ||
| Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations | Q35829217 | ||
| Human parvovirus B19 infection and antiphospholipid-syndrome: the two sides of one medal? | Q36326309 | ||
| Infectious origin of the antiphospholipid syndrome | Q36339540 | ||
| Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis | Q39970029 | ||
| Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein | Q40327143 | ||
| Matrix metalloproteinases in immunity. | Q40968642 | ||
| Interfacial enzymology of parvovirus phospholipases A2. | Q44730632 | ||
| Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus | Q45050925 | ||
| Beneficial effects of treatment with cystamine on brain in NZB/W F1 mice. | Q46487771 | ||
| Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities | Q47948566 | ||
| Beneficial effects of treatment with transglutaminase inhibitor cystamine on macrophage response in NZB/W F1 mice. | Q54559644 | ||
| The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. | Q54707025 | ||
| Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection | Q73628348 | ||
| Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus | Q77723474 | ||
| Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides | Q78248010 | ||
| Differential inductions of matrix metalloproteinase-2 and -9 in host tissues during the growth of ascitic sarcoma 180 cells in mice | Q78555018 | ||
| The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production | Q79433642 | ||
| Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein | Q81419785 | ||
| P304 | page(s) | 14 | |
| P577 | publication date | 2009-01-26 | |
| P1433 | published in | Journal of Biomedical Science | Q15759332 |
| P1476 | title | Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein | |
| P478 | volume | 16 |
| Q34808812 | Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice |
| Q42338994 | Hepatic inflammation resulting from localized, subcutaneous expression of Parvovirus VP1u capsid protein: Importance and implication |
| Q37197356 | Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice |
| Q46115768 | Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis |
| Q51740190 | Secondhand smoke induces hepatic apoptosis and fibrosis in hamster fetus. |
| Q35714389 | Selfness-nonselfness in designing an anti-B19 erythrovirus vaccine |
Search more.